Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial

BACKGROUND: Dyslipidemia is a risk factor for the progression of chronic kidney disease (CKD). While conventional lipid lowering therapy provides a benefit to CKD management, the effect of statins on eGFR remains unclear. METHODS: A prospective, multi-center, open-labeled, randomized trial. Total of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Exp Nephrol
Asıl Yazarlar: Kimura, Genjiro, Kasahara, Masato, Ueshima, Kenji, Tanaka, Sachiko, Yasuno, Shinji, Fujimoto, Akira, Sato, Toshiya, Imamoto, Miyuki, Kosugi, Shinji, Nakao, Kazuwa
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Japan 2016
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5486454/
https://ncbi.nlm.nih.gov/pubmed/27392909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10157-016-1304-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller